Diamedica Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Diamedica Therapeutics Inc
TickerDMAC
CIK #0001401040
CUSIP25253X207
SectorLife Sciences - Pharmaceutical Preparations
Address2 Carlson Parkway Suite 260, Minneapolis, MN 55447
Source [EDGAR]
CIK Filing 2011 - 2025
[0001401040] 10-K
[0001401040] 10-Q
[0001401040] 3
[0001401040] 4
[0001401040] 8-K
[0001401040] D
[0001401040] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Dialectic Capital Management LP Diamedica Therapeutics Inc [2024-07-08] 5.1
Jacinto Richard II Diamedica Therapeutics Inc [2022-05-27] 6.2
Trill AB Diamedica Therapeutics Inc [2021-10-08] 0.6
Tomenterprise AB Diamedica Therapeutics Inc [2021-10-08] 0.6
Lytton Laurence W Diamedica Therapeutics Inc [2021-10-06] 5.2
Stonepine Capital Management LLC Diamedica Therapeutics Inc [2020-02-12] 5.7
Hirschman Orin Diamedica Therapeutics Inc [2019-04-29] 6.35
Chang Nancy T Diamedica Therapeutics Inc [2019-02-01] 5.5
Centrestone Ventures Limited Partnership Diamedica Therapeutics Inc [2019-01-29] 5.0
Xiao Zhenyu Diamedica Therapeutics Inc [2019-01-24] 8.4
Form 3/4/5 Filer 2011 - 2025
TomEnterprise Private AB
TomEnterprise AB
DiaMedica Therapeutics Inc.
Von Koch Thomas
Jacinto Richard II
Stahlberg Jan
Trill AB
Giuffre Randall Michael
Wambeke David J.
Semba Charles Pauling
Pauls Dietrich John
Parsons James T.
Lewis Tanya
Kuntz Richard
Kellen Scott
Pilnik Richard D.
O'Connor Daniel J.
Cundari Dominic R
Lorianne Masuoka K.
Daves Julie VanOrsdel
Gruis Kirsten L
Burroughs Amy L.
Alcorn Harry W Jr
Gilman Sydney A.
Xiao Zhenyu
Verdoorn Todd A.
Hermeda Industrial Co., Ltd
Form 13F Holdings
Firm Period DFND Voting Shares
Cooperman Leon G [2025-06-30] SOLE 1,650,000 1,650,000
Vanguard Group Inc [2025-06-30] SOLE 0 1,501,544
BlackRock, Inc. [2025-06-30] SOLE 1,169,174 1,191,813
Paragon Associates & Paragon Associates II Joint Venture [2025-06-30] SOLE 650,000 650,000
Geode Capital Management LLC [2025-06-30] DFND 630,148 630,148
First Manhattan Co LLC [2025-06-30] SOLE 0 606,435
Bleichroeder LP [2025-06-30] SOLE 382,317 382,317
Northern Trust Corp [2025-06-30] DFND 320,491 320,491
State Street Corp [2025-06-30] DFND 224,714 251,948
Morgan Stanley [2025-06-30] DFND 207,476 240,476
LPL Financial LLC [2025-06-30] SOLE 0 197,500
Charles Schwab Investment Management Inc [2025-06-30] SOLE 79,553 79,553
Royal Bank of Canada [2025-06-30] DFND 76,224 77,054
Blue Trust, Inc. [2025-06-30] SOLE 69,122 69,122
Marshall Wace LLP [2025-06-30] OTR 0 61,719
Bank of New York Mellon Corp [2025-06-30] DFND 59,034 60,065
Perigon Wealth Management LLC [2025-06-30] SOLE 0 53,000
Barclays PLC [2025-06-30] SOLE 48,773 48,773
Catalyst Financial Partners LLC [2025-06-30] SOLE 0 38,457
Nuveen, LLC [2025-06-30] DFND 34,347 34,347
Vanguard Group Inc [2025-06-30] DFND 0 33,510
Susquehanna International Group LLP [2025-06-30] OTR 32,796 32,796
World Investment Advisors [2025-06-30] SOLE 0 31,975
Meridian Wealth Management LLC [2025-06-30] SOLE 20,816 27,316
New York State Common Retirement Fund [2025-06-30] SOLE 26,300 26,300
RhumbLine Advisers [2025-06-30] SOLE 11,024 23,894
BNP Paribas Financial Markets [2025-06-30] DFND 0 18,882
Goldman Sachs Group Inc [2025-06-30] DFND 17,904 17,904
Stonebridge Capital Advisors LLC [2025-06-30] SOLE 17,500 17,500
Jones Financial Companies LLLP [2025-06-30] SOLE 16,622 16,622
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com